Core Insights - The Trade Desk (TTD) reported quarterly earnings of $0.45 per share, exceeding the Zacks Consensus Estimate of $0.44 per share, and showing an increase from $0.41 per share a year ago, resulting in an earnings surprise of +2.27% [1] - The company achieved revenues of $739.43 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 2.96% and up from $628.02 million year-over-year [2] - The Trade Desk has outperformed consensus EPS estimates three times in the last four quarters and has also topped revenue estimates three times during the same period [2] Earnings Outlook - The immediate price movement of The Trade Desk's stock will largely depend on management's commentary during the earnings call and future earnings expectations [3][4] - The current consensus EPS estimate for the upcoming quarter is $0.59 on revenues of $831.27 million, while the estimate for the current fiscal year is $1.76 on revenues of $2.86 billion [7] Industry Context - The Internet - Services industry, to which The Trade Desk belongs, is currently ranked in the top 39% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact The Trade Desk's stock performance [5]

Core Insights - Yelp reported quarterly earnings of $0.61 per share, exceeding the Zacks Consensus Estimate of $0.47 per share, and showing an increase from $0.56 per share a year ago, resulting in an earnings surprise of +29.79% [1] - The company achieved revenues of $376.04 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 2.29% and up from $360.34 million year-over-year [2] - Yelp has consistently surpassed consensus EPS and revenue estimates over the last four quarters [2] Earnings Performance - The earnings surprise of +29.79% indicates strong performance relative to expectations, with a previous quarter's surprise of +39.58% [1] - The company has shown a pattern of exceeding consensus estimates, with four consecutive quarters of positive surprises in both EPS and revenue [2] Stock Performance - Yelp shares have declined approximately 16.9% year-to-date, contrasting with the S&P 500's gain of 15.6% [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating expectations of underperformance in the near future [6] Future Outlook - The consensus EPS estimate for the upcoming quarter is $0.57, with projected revenues of $371.48 million, while the estimate for the current fiscal year is $2.08 on $1.47 billion in revenues [7] - The sustainability of the stock's price movement will depend on management's commentary during the earnings call and future earnings expectations [3][4]

Core Insights - Lifecore Biomedical reported a quarterly loss of $0.29 per share, slightly better than the Zacks Consensus Estimate of a loss of $0.30, and an improvement from a loss of $0.53 per share a year ago, indicating an earnings surprise of +3.33% [1] - The company achieved revenues of $31.11 million for the quarter ended August 2025, exceeding the Zacks Consensus Estimate by 16.60%, and showing growth from $24.7 million in the same quarter last year [2] - Lifecore Biomedical has surpassed consensus EPS estimates two times over the last four quarters and topped consensus revenue estimates three times during the same period [2] Stock Performance - Lifecore Biomedical shares have declined approximately 8.9% since the beginning of the year, contrasting with the S&P 500's gain of 15.6% [3] - The future price movement of the stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [3][4] Earnings Outlook - The estimate revisions trend for Lifecore Biomedical was mixed ahead of the earnings release, leading to a Zacks Rank 3 (Hold) for the stock, suggesting it is expected to perform in line with the market in the near future [6] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Core Viewpoint - Bel Fuse (BELFB) has received an upgrade to a Zacks Rank 1 (Strong Buy), indicating a positive trend in earnings estimates which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system is based on changes in earnings estimates, which are closely correlated with near-term stock price movements [4][6]. - Institutional investors often rely on earnings estimates to determine the fair value of stocks, leading to significant price movements when estimates are revised [4]. Business Outlook for Bel Fuse - The upgrade in Zacks Rank suggests an improvement in Bel Fuse's underlying business, which could lead to an increase in stock price as investors respond positively to this trend [5][10]. - For the fiscal year ending December 2025, Bel Fuse is expected to earn $6.80 per share, with a 17.4% increase in the Zacks Consensus Estimate over the past three months [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [7]. - Only the top 5% of Zacks-covered stocks receive a "Strong Buy" rating, indicating superior earnings estimate revisions and potential for market-beating returns [9][10].

Core Viewpoint - Liquidia Corporation (LQDA) has seen a 9.7% increase in share price over the past four weeks, closing at $26.42, with a potential upside of 62.3% based on Wall Street analysts' mean price target of $42.89 [1] Price Targets - The average price target consists of nine estimates ranging from a low of $6.00 to a high of $67.00, with a standard deviation of $16.92, indicating variability among analysts [2] - The lowest estimate suggests a decline of 77.3%, while the highest indicates a potential upside of 153.6% [2] - A low standard deviation signifies greater agreement among analysts regarding price movement [2][9] Analyst Sentiment - Analysts have shown increasing optimism about LQDA's earnings prospects, with a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [4][11] - Over the last 30 days, four earnings estimates have been revised upward, leading to a 45.4% increase in the Zacks Consensus Estimate for the current year [12] Zacks Rank - LQDA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] Conclusion on Price Targets - While the consensus price target may not be a reliable measure of the extent of potential gains, it does provide a useful indication of the expected direction of price movement [14]

Core Viewpoint - Rapid7 (RPD) has experienced a significant decline of 22.7% over the past four weeks, but it is now in oversold territory, indicating a potential for a trend reversal as analysts expect better earnings than previously predicted [1] Group 1: Technical Indicators - The Relative Strength Index (RSI) is a key technical indicator used to determine if a stock is oversold, with readings below 30 typically indicating this condition [2] - RPD's current RSI reading is 22.29, suggesting that the heavy selling pressure may be exhausting itself, which could lead to a reversal towards the previous equilibrium of supply and demand [5] Group 2: Fundamental Indicators - There is a strong consensus among sell-side analysts that RPD's earnings estimates for the current year have increased by 1.5% over the last 30 days, which often correlates with price appreciation in the near term [7] - RPD holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, indicating a strong potential for a turnaround [8]

Core Viewpoint - Kohl's (KSS) is showing potential for investment due to a recent technical breakout and positive earnings revisions [1][2][3] Technical Analysis - KSS has recently broken above the 50-day moving average, indicating a short-term bullish trend [1] - The stock has reached a key level of support, which is a positive sign for investors [1] Performance Metrics - Over the past four weeks, KSS has gained 11.5%, suggesting strong momentum [2] - The current Zacks Rank for KSS is 3 (Hold), indicating potential for further upward movement [2] Earnings Estimates - There have been three upward revisions in earnings estimates for the current fiscal year, with no downward revisions [2] - The consensus earnings estimate has also increased, reinforcing the bullish outlook for KSS [2][3]

Core Insights - Netlist, Inc. reported a quarterly loss of $0.02 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.01, marking an earnings surprise of -100.00% [1] - The company generated revenues of $42.23 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 0.56% and showing an increase from $40.19 million year-over-year [2] - Netlist shares have declined approximately 21.7% year-to-date, contrasting with the S&P 500's gain of 15.6% [3] Financial Performance - Over the last four quarters, Netlist has consistently failed to surpass consensus EPS estimates [2] - The current consensus EPS estimate for the upcoming quarter is -$0.01 on revenues of $47 million, while for the current fiscal year, it is -$0.07 on revenues of $159.7 million [7] Market Outlook - The company's earnings outlook will be crucial for understanding future stock performance, particularly in light of management's commentary during the earnings call [3][4] - The Zacks Rank for Netlist is currently 3 (Hold), indicating that shares are expected to perform in line with the market in the near future [6] Industry Context - The Computer-Storage Devices industry, to which Netlist belongs, is currently ranked in the top 17% of over 250 Zacks industries, suggesting a favorable industry outlook [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Core Insights - Golden Entertainment reported a quarterly loss of $0.18 per share, missing the Zacks Consensus Estimate of a loss of $0.08, and compared to earnings of $0.18 per share a year ago, indicating an earnings surprise of -125.00% [1] - The company posted revenues of $154.82 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 0.98% and down from $161.23 million year-over-year [2] - Golden Entertainment shares have declined approximately 32.8% since the beginning of the year, contrasting with the S&P 500's gain of 15.6% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.13 on revenues of $167.48 million, and for the current fiscal year, it is $0.31 on revenues of $648.32 million [7] - The estimate revisions trend for Golden Entertainment was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Gaming industry, to which Golden Entertainment belongs, is currently in the top 33% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - GameSquare Holdings, Inc., another company in the same industry, is expected to report a quarterly loss of $0.03 per share, reflecting a year-over-year change of +78.6% [9]

Core Viewpoint - Alcon is expected to report quarterly earnings of $0.77 per share, a decline of 4.9% year-over-year, with revenues projected at $2.59 billion, reflecting a 6.5% increase compared to the previous year [1] Earnings Projections - The consensus EPS estimate for the quarter has remained unchanged over the past 30 days, indicating analysts' reassessment of their initial projections [1][2] Key Metrics Forecast - Analysts predict 'Net Sales- Total Surgical' to be $1.42 billion, a 6.1% increase from the prior-year quarter [4] - 'Net Sales- Total Vision Care' is expected to reach $1.17 billion, suggesting a 7.1% year-over-year change [4] Detailed Sales Estimates - 'Net Sales- Total Surgical- Consumables' is estimated at $743.89 million, reflecting a 6.1% increase from the previous year [5] - 'Net Sales- Total Surgical- Equipment/other' is projected at $245.51 million, indicating a 14.2% year-over-year increase [5] - 'Net Sales- Total Vision Care- Contact lenses' is expected to be $724.58 million, a 9.1% increase year-over-year [6] - 'Net Sales- Total Vision Care- Ocular health' is forecasted at $448.60 million, showing a 4.1% change from the prior-year quarter [6] Regional Sales Forecast - 'Net Sales- Total Surgical- Implantables' is projected to reach $430.00 million, a 1.9% increase from the previous year [7] - 'Revenues- Other revenues' are expected to be $19.52 million, indicating a 7.1% decline year-over-year [7] - 'Net sales by region- United States' is forecasted at $1.16 billion, reflecting a 4.6% year-over-year increase [7] - 'Net sales by region- International' is expected to reach $1.43 billion, suggesting an 8.2% increase from the prior-year quarter [8] Stock Performance - Alcon shares have decreased by 2.9% in the past month, contrasting with the Zacks S&P 500 composite's increase of 1.3% [8] - With a Zacks Rank 2 (Buy), Alcon is anticipated to outperform the overall market performance in the near term [8]